Aspirin in low-doses is commonly prescribed to prevent cardiovascular diseases. But a recent study claimed that gene variations in some individuals may lead to slightly harmful effects on these patients. As per the researchers a common genetic variation in the gene of the enzyme catechol-O-methyltransferase (COMT) is responsible for altering the cardiovascular benefits of the drug. (Read: Aspirin might just be what you need to keep heart disease at bay) COMT is a key enzyme in the metabolism of catecholamines a group of hormones that include epinephrine norepinephrine and dopamine. 'This is one of the few cases where you can